Investigation of platelet-rich plasma in rabbit cranial defects: A pilot study

2002 ◽  
Vol 60 (10) ◽  
pp. 1176-1181 ◽  
Author(s):  
Tara L. Aghaloo ◽  
Peter K. Moy ◽  
Earl G. Freymiller
Keyword(s):  
Pilot Study ◽  
Platelet Rich Plasma

627-P: Efficacy and Safety of Allogeneic Platelet Rich Plasma in Treatment of Diabetic Patients with Lower Limb Ulcers: A Pilot Study

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 627-P
Author(s):  
WUQUAN DENG ◽  
MIN HE ◽  
BING CHEN ◽  
YU MA ◽  
DAVID ARMSTRONG ◽  
...  
Keyword(s):  
Pilot Study ◽  
Lower Limb ◽  
Platelet Rich Plasma ◽  
Diabetic Patients ◽  
Efficacy And Safety

scholarly journals Reactivating Ovarian Function through Autologous Platelet-Rich Plasma Intraovarian Infusion: Pilot Data on Premature Ovarian Insufficiency, Perimenopausal, Menopausal, and Poor Responder Women

2020 ◽  
Vol 9 (6) ◽  
pp. 1809 ◽  
Author(s):  
Konstantinos Sfakianoudis ◽  
Mara Simopoulou ◽  
Sokratis Grigoriadis ◽  
Agni Pantou ◽  
Petroula Tsioulou ◽  
...  
Keyword(s):  
Pilot Study ◽  
Outcome Measures ◽  
Primary Outcome ◽  
Platelet Rich Plasma ◽  
Premature Ovarian Insufficiency ◽  
Cycle Performance ◽  
Routine Practice ◽  
Ovarian Insufficiency ◽  
Pilot Studies ◽  
Pilot Data

Intraovarian platelet-rich plasma (PRP) infusion was recently introduced in the context of addressing ovarian insufficiency. Reporting on its effectiveness prior to adopting in clinical routine practice is imperative. This study aims to provide pilot data regarding PRP application for ovarian rejuvenation. Four pilot studies were conducted on poor ovarian response (POR), premature ovarian insufficiency (POI), perimenopause, and menopause, respectively. Each pilot study reports on thirty patients, 120 participants were recruited in total. All participants provided written informed consent prior to treatment. Primary outcome measures for the POR pilot study were levels of anti-müllerian hormone (AMH), antral follicle count (AFC) and oocyte yield. For the POI, perimenopausal and menopausal pilot studies primary outcome measures were restoration of menstrual cycle, and Follicle Stimulating Hormone (FSH) levels. A significant improvement on the hormonal profile and the ovarian reserve status was noted, along with improved intracytoplasmic sperm injection (ICSI) cycle performance concerning POR participants. Menstruation recovery was observed in 18 out of 30 POI patients, along with a statistically significant improvement on levels of AMH, FSH, and AFC. Similarly, 13 out of 30 menopausal women positively responded to PRP treatment. Finally, menstruation regularity, improved hormonal levels and AFC were reported for 24 out of 30 perimenopausal women. To conclude, PRP infusion appears to convey promising results in addressing ovarian insufficiency.

Platelet‐rich plasma treatment for melasma: A pilot study

2019 ◽  
Vol 19 (6) ◽  
pp. 1321-1327 ◽  
Author(s):  
Punyaphat Sirithanabadeekul ◽  
Arada Dannarongchai ◽  
Atchima Suwanchinda
Keyword(s):  
Pilot Study ◽  
Plasma Treatment ◽  
Platelet Rich Plasma

scholarly journals Intraosseous infiltrations of Platelet-Rich Plasma for severe hip osteoarthritis: A pilot study

2020 ◽  
Vol 11 ◽  
pp. S585-S590
Author(s):  
Nicolás Fiz ◽  
Diego Delgado ◽  
Ane Garate ◽  
Pello Sánchez ◽  
Jaime Oraa ◽  
...  
Keyword(s):  
Pilot Study ◽  
Platelet Rich Plasma ◽  
Hip Osteoarthritis
Sign in / Sign up

Export Citation Format

Share Document